Raed Alroughani received a degree in medicine from Charles University. He finished his neurology residency from the University of British Columbia and obtained the neurology certification from the Royal College of Physicians & Surgeon, Canada. He finished his fellowship in demyelinating disorders at the University of British Columbia. He worked as attending neurologist at the Royal Columbian Hospital, Canada, after which he joined the division of neurology at Amiri Hospital, Kuwait. Dr. Alroughani established the first multi-disciplinary MS clinic at Dasman Research Institute in 2011. He currently serves as a director of MS clinic in Dasman Research Institute and as a head for parallel MS clinics in Amiri and Ibn-Sina hospitals. Dr. Alroughani is involved in several clinical trials, mainly in the field of multiple sclerosis. He served as a member of the joint ethical committee formed by Kuwait University and Ministry of Health. He is the past treasurer of the Kuwait Neurological Society. He currently sits on the executive boards of various scientific associations, steering committees and advisory boards, mainly in the field of MS. Dr. Alroughani’s fields of interest are principally directed towards the epidemiology and therapeutics of multiple sclerosis. He established the first national MS registry in Kuwait. He currently serves in the scientific leadership group of MS Base, which represents the largest international MS database involving more than 60 countries. He has authored and co-authored more than 30 articles in peer-reviewed journals in the last 3 years.